Immunogenicity of LY2963016 insulin glargine and Lantus (R) insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus

Wang, WM; Song, X; Lou, Y; Du, LY; Zhu, DL; Zhou, ZG

Zhu, DL (通讯作者),Nanjing Univ, Drum Tower Hosp, Dept Endocrinol, Med Sch, Nanjing 210008, Peoples R China.;Zhou, ZG (通讯作者),Cent South Univ, Dept Metab & Endocrinol, Xiangya Hosp 2, 139 Renmin Rd, Changsha 410011, Peoples R China.

DIABETES OBESITY & METABOLISM, 2022; 24 (6): 1094

Abstract

Aims To evaluate the immunogenicity of LY2963016 insulin glargine (LY IGlar) versus originator insulin glargine (IGlar [Lantus (R)]) in Chinese patien......

Full Text Link